General Information of Drug (ID: DMGN4OQ)

Drug Name
ISIS-1939 Drug Info
Synonyms 136216-59-6
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMGN4OQ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
lifitegrast DM4WVC5 Dry eye disease 9E1Z Approved [2]
Alicaforsen DMQ509J Lleum inflammation 1A40.0 Phase 3 [3]
BI-505 DMSZQHX Multiple myeloma 2A83 Phase 2 [4]
APC-8015F DM3VP19 Prostate cancer 2C82.0 Phase 2 [5]
AIC100 DMSPBOW Thyroid cancer 2D10 Phase 1 [6]
GI-270384X DM3KN2Q Inflammatory bowel disease DD72 Terminated [7]
A-252444.0 DMDTA36 Inflammation 1A00-CA43.1 Terminated [8]
MOR-102 DMRCH1M Psoriasis vulgaris EA90 Terminated [9]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Intercellular adhesion molecule ICAM-1 (ICAM1) TTCT6F7 ICAM1_HUMAN Modulator [1]

References

1 Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem. 1991 Sep 25;266(27):18162-71.
2 Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye. ACS Med Chem Lett. 2012 Jan 31;3(3):203-6.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo. Cancer Cell. 2013 Apr 15;23(4):502-15.
5 National Cancer Institute Drug Dictionary (drug id 561410).
6 Clinical pipeline report, company report or official report of AffyImmune Therapeutics.
7 Inhibition of endothelial cell adhesion molecule expression improves colonic hyperalgaesia. Neurogastroenterol Motil. 2009 Feb;21(2):189-96.
8 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012566)
9 Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model. Br J Dermatol. 2005 Oct;153(4):758-66.